Celera Pharma

India
Pharmaceutical formulations in healthcare sectors including Nephrology and Cardiology.

About Celera Pharma

Celera Pharma is a Healthcare company based in India. Pharmaceutical formulations in healthcare sectors including Nephrology and Cardiology. Its Indian entity Celera Pharma Private Limited reported revenue of β‚Ή22.48 Cr. Celera Pharma offers products and services including Nephrology Products and Cardiology Products. Its focus areas include Pharmaceuticals, Nephrology, Formulations and Cardiology.

Company details

Celera Pharma is recognized as a leading biotechnology company that markets formulations across India, focusing on areas such as Nephrology, Cardiology, General Medicine, Urology, and Neurology. Quality medicines are delivered to enhance patient healthcare, with an emphasis on improving life quality through innovative offerings. The company is guided by principles of relentless growth via change management, empowerment of diverse abilities, and commitment to social responsibility for the common good. Continuous pursuit of excellence is maintained in its operations.

  • Headquarters India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website celerapharma.in
  • Legal Name Celera Pharma Pvt. Ltd
  • Date of Incorporation 03 Feb, 2011
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹22.48 Cr

    FY 2025 · +23% YoY

  • Net Profit
    ₹97.8 Lakh

    FY 2025 · 4% margin

  • EBITDA
    ₹1.38 Cr

    FY 2025 · 6% margin

Products & Services of Celera Pharma

Celera Pharma offers a comprehensive portfolio of products and services, including Nephrology Products and Cardiology Products.

Nephrology Products
Pharmaceuticals

Nephrology formulations are marketed for essential healthcare needs.

Cardiology Products
Pharmaceuticals

Cardiology medicines are provided as part of the product range for patient care.

Board of directors of Celera Pharma Private Limited (Celera Pharma)

Celera Pharma Private Limited is the primary company behind Celera Pharma. The board of Celera Pharma Private Limited currently have 2 directors; the longest-serving is Sabitha Kalluri, appointed in 2014. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sabitha Kalluri
DIN 06975630
Director20 Sep 201412 yrs 2 moCelera Pharma Private Limited
Ravi Mahanthi
DIN 09694871
Director04 Aug 20224 yrs 3 moCelera Pharma Private Limited

Financials of Celera Pharma

Figures of Celera Pharma Private Limited, the primary company behind Celera Pharma, for FY 2025. Revenue was ₹22.48 Cr (+23% year on year). Net profit was ₹97.8 Lakh (4% margin). EBITDA was ₹1.38 Cr (6% margin). Revenue has grown at a compounded annual rate of 0% over three years and +15% over five years.

  • ₹22.48 CrRevenue · FY 2025 · +23% YoY
  • ₹97.8 LakhNet profit · 4% margin
  • ₹1.38 CrEBITDA · 6% margin
  • ₹1 LakhPaid-up capital
  • 0%Revenue CAGR, 3 years
  • +15%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Celera Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Celera Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Celera Pharma

Celera Pharma is headquartered in India.

The primary company behind Celera Pharma, Celera Pharma Private Limited, reported revenue of β‚Ή22.48 Cr for FY 2025, up 23% year on year.

Celera Pharma is recognized as a leading biotechnology company that markets formulations across India, focusing on areas such as Nephrology, Cardiology, General Medicine, Urology, and Neurology. Quality medicines are delivered to enhance patient healthcare, with an emphasis on improving life quality through innovative offerings. The company is guided by principles of relentless growth via change management, empowerment of diverse abilities, and commitment to social responsibility for the common good. Continuous pursuit of excellence is maintained in its operations.

Celera Pharma offers Nephrology Products and Cardiology Products.

Celera Pharma operates through Celera Pharma Private Limited.

The legal entities of Celera Pharma currently have 2 directors, including Sabitha Kalluri, Ravi Mahanthi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available